UniQure

UniQure

UniQure

uniQure is a world leader in the development of human gene based therapies for hemophilia B, acute intermittent porphyria, Parkinson’s disease and SanfilippoB.
Founded
2012
Raised
$78M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$20,000,000
Debt financing - 2014
Hercules Technology Growth Capital
$58,000,000
Private equity - 2013
Coller Capital
Team Size
50+
Employees
Xconomy

For Key Study, UniQure Allowed to Swap Hemophilia Gene Therapies

Health Science
Xconomy

UniQure to Yank Pioneering Gene Therapy From Market in Europe

Health Science
Xconomy

Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring

Health Strategy
The Motley Fool , Xconomy

Here's Why uniQure N.V.'s Stock Spiked Today --